Post
· Views 22
中药板块在9月的反弹中稍显弱势,因其前期表现相对生物制品、医疗器械等其他医药子板块更加抗跌稳健,政策也一直给予呵护,风格偏向医药防御性资产

Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.

FOLLOWME Trading Community Website: https://www.followme.com

avatar

Hot

No comment on record. Start new comment.